Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Convertible and Equity Facility Draw Downs

8 Dec 2021 07:00

RNS Number : 8959U
Kropz PLC
08 December 2021
 

8 December 2021

Kropz Plc

("Kropz" or the "Company")

 

Equity Facility and Convertible Equity Facility Draw Downs

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, is pleased to confirm that it has made its fourth draw down request under the US$ 5 million Equity Facility from ARC Fund ("ARC"), the Company's major shareholder (which cannot exceed ZAR 85 million) ("New Equity Facility"), as announced on 26 February 2021.

 

The fourth draw down request of US$ 400,000 under the New Equity Facility will be settled by the issue of 6,949,072 new ordinary shares at the issue price of 4.20 pence per share to ARC on 13 December 2021.

 

The proceeds drawn down from the New Equity Facility will be applied to the continuing workstream on the Hinda project and for general corporate purposes.

 

The next draw down of US$200,000 under the New Equity Facility is expected to be made on or about 10 March 2021. Following this drawdown, the New Equity Facility will be fully drawn down.

 

In addition, Kropz announced on 29 September 2021 that it had entered into a new conditional convertible equity facility of up to ZAR 200 million ("New ZAR Equity Facility"), with ARC, in order to deliver the Company's Elandsfontein phosphate project to first revenue. The first drawdown of ZAR90 million of the New ZAR Equity Facility was made on 26 October 2021.

The second drawdown of ZAR37 million of the New ZAR Equity Facility will be made on 10 December 2021. If required, the ZAR73 million remaining on the New ZAR Equity Facility will be drawn down in Q1 2022.

 

The Company will provide further updates on Elandsfontein and Hinda project progress in late Q4 2021.

 

Admission and Total Voting Rights

 

Application will be made for the 6,949,072 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 13 December 2021 ("Admission").

 

On Admission, the Company's issued share capital will consist of 909,571,975 ordinary shares with voting rights. There are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Change in Shareholding

 

Following issue of the 6,949,072 new ordinary shares, ARC will be directly interested in 760,893,082 ordinary shares of the Company representing 83.65 per cent. of the issued share capital.

 

 

 

For further information visit www.kropz.com or contact:

 

Kropz Plc

 

Mark Summers (CEO)

+27 (0) 79 744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

 

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0) 20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0) 11 880 3924

james@rasc.co.za 

 

About Kropz Plc

Kropz is an emerging African explorer and developer of plant nutrient feed minerals with phosphate projects in South Africa and the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBSWRABUURAA
Date   Source Headline
7th Jul 202211:33 amRNSDrawdown on Equity Facility
30th Jun 20222:13 pmRNSResult of AGM
30th Jun 20227:00 amRNSFinal Results for the Year ended 31 December 2021
7th Jun 20229:33 amRNSNotice of Annual General Meeting
6th Jun 202211:05 amRNSSecond Price Monitoring Extn
6th Jun 202211:00 amRNSPrice Monitoring Extension
6th Jun 20227:00 amRNSUpdate on New Convertible Facility Agreement
30th May 20222:05 pmRNSResult of General Meeting
11th May 20228:55 amRNSNew Convertible Facility Agreement and GM Notice
28th Apr 20227:27 amRNSBridge Loan Facility Drawdown
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSElandsfontein Update and Bridge Loan Facility
20th Apr 20224:40 pmRNSSecond Price Monitoring Extn
20th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 20227:30 amRNSOperational Activities
31st Mar 20227:00 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSFirst production from Elandsfontein
16th Mar 20222:35 pmRNSConvertible Equity Facility Draw Downs
16th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:37 pmRNSPrice Monitoring Extension
7th Mar 20227:00 amRNSEquity Facility Draw Down
31st Jan 20227:00 amRNSTotal Voting Rights
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:00 amRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20222:05 pmRNSSecond Price Monitoring Extn
21st Jan 20222:01 pmRNSPrice Monitoring Extension
21st Jan 202211:05 amRNSSecond Price Monitoring Extn
21st Jan 202211:00 amRNSPrice Monitoring Extension
21st Jan 20229:05 amRNSSecond Price Monitoring Extn
21st Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 202210:53 amRNSLong Term Incentive Plan Awards
31st Dec 20217:00 amRNSTotal Voting Rights
23rd Dec 20217:00 amRNSIntroduction of first ore to Elandsfontein plant
22nd Dec 20217:00 amRNSHinda Update
8th Dec 20217:00 amRNSConvertible and Equity Facility Draw Downs
23rd Nov 20219:39 amRNSUpdate on Elandsfontein and Hinda projects
22nd Nov 20214:41 pmRNSSecond Price Monitoring Extn
22nd Nov 20214:36 pmRNSPrice Monitoring Extension
21st Oct 20217:00 amRNSUpdate on New Convertible Facility Agreement
15th Oct 202112:52 pmRNSResult of General Meeting
11th Oct 20217:00 amRNSUpdate on New Convertible Facility Agreement
30th Sep 20217:00 amRNSTotal Voting Rights
29th Sep 20217:00 amRNSNew Convertible Facility Agreement and GM Notice
9th Sep 20214:03 pmRNSUpdate on Appeal against Water Use Licence
7th Sep 20217:00 amRNSEquity Facility Draw Downs
1st Sep 20217:00 amRNSUnaudited Half Year Results for H1 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.